Open access
Aug 2026
IL-6-driven metabolic reprogramming of the multiple myeloma microenvironment
Bone marrow stromal cell-derived interleukin-6 is identified as a central driver of tumor microenvironment-mediated metabolic reprogramming and bortezomib resistance in multiple myeloma.
María Matamala Montoya, Silke Eleveld, E. Zaal et al.
· Cancer & Metabolism · 0 citations